The pharmacokinetics of tirzepatide after a single 5 mg dose was evaluated in patients with different degrees of hepatic impairment (mild, moderate, severe) compared with subjects with normal hepatic function [see Use in Specific Populations (8.7)]
Given their non-invasive nature, accessibility, and cost-effectiveness of sublingual formulations, they may represent a promising approach for long-term B12 management, particularly in patients with impaired absorption or in resource-limited settings
The HCG Institute is a patient management platform that partners with independent licensed physician networks to deliver medical services through our infrastructure.This content is educational and is not considered medical advice
Peptides such as AOD-9604 have been developed to explore signalling pathways and receptor interactions in controlled laboratory environments
Blood work showing high LH and FSH naturally (before HCG) suggests primary failure, which responds poorly to HCG